Abstract:Both type 1 and type 2 diabetes (T1D and T2D) result from chronic insulin insufficiency due to progressive dysfunction and loss of beta cells, driven by cellular stress. Beta cell failure in both forms of diabetes involves defective stress-response and the onset of premature senescence, an irreversible form of cell-cycle arrest induced by chronic stress. However, the mechanisms by which cellular stress triggers beta cell senescence are not clear. We now show that CTCF, a stress-sensitive epigenetic regulator, controls the beta cell stress-response and senescence programs during beta cell maturation process along with the cohesin Smc3. Chromatin immunoprecipitation data suggest that CTCF and Smc3 differentially occupy genes associated with stress and DNA damage responses, functional maturation, and senescence in neonatal versus adult beta cells. Our data show that CTCF and cohesin Smc3 dependent control protects replicating beta cells from DNA damage, and is especially critical during the neonatal growth phase marked by high rates of replication. Beta cell specific loss of CTCF triggers a p53/p21 dependent senescence program, followed by beta cell dysfunction and eventual beta cell failure with advancing age. We further demonstrate that reduced CTCF levels in beta cells lead to adaptive failure in response to a high fat diet challenge, and recapitulate a neonatal beta cell like epigenetic landscape. Notably, CTCF levels are reduced in beta cells in T1D and T2D in mice and humans, and lead to reduced occupancy of CTCF and Smc3 at genes involved in senescence, DNA damage response, and beta cell function. Our data show that CTCF and cohesin collectively protect against senescence and govern beta cell function and fitness through a program established in the neonatal maturation phase. Disclosure S.S.Varghese: None. N.Parveen: None. J.K.Wang: Employee; Pfizer Inc., Johnson & Johnson. A.G.Hernandez-de la pena: None. S.Dhawan: None. Funding National Institutes of Health (R01DK120253)

Aging Impairs Adaptive Unfolded Protein Response and Drives Beta Cell Dedifferentiation in Humans

Aging compromises human islet beta cell function and identity by decreasing transcription factor activity and inducing ER stress

Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors

A single-cell transcriptomic atlas of primate pancreatic islet aging

Senescence of human pancreatic beta cells enhances functional maturation through chromatin reorganization and promotes interferon responsiveness

Modulation of Pancreatic Islets' Function and Survival During Aging Involves the Differential Regulation of Endoplasmic Reticulum Stress by p21 and CHOP

Investigation of Pancreatic-beta Cells Role in the Biological Process of Ageing

Aging and Stress Induced Β Cell Senescence and Its Implication in Diabetes Development

Aging and sleep deprivation induce the unfolded protein response in the pancreas: implications for metabolism

The pathological characters of islets aging in old rhesus monkeys

375-OR: Epigenetic Control of Beta-Cell Stress Response and Senescence

Age-related Hyperinsulinemia Leads to Insulin Resistance in Neurons and Cell-Cycle-induced Senescence

The effects of aging on pancreatic islet β cells function

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

Senescence: a double-edged sword in beta-cell health and failure?

Forkhead Box Protein 1 (FoxO1) Inhibits Accelerated β Cell Aging in Pancreas-specific SMAD7 Mutant Mice

Altered cellular heterogeneity as a possible mechanism for the maintenance of organ function in senescent animals

Pancreatic β-cell senescence in diabetes: mechanisms, markers and therapies

Increased glycolysis affects β-cell function and identity in aging and diabetes

Is Β‐cell Aging Involved in the Pathogenesis of Diabetes?

Alpha cell dysfunction in type 1 diabetes is independent of a senescence program